2m 2m 2m 2m 2m 2m 2m
Coherus Onco (CHRS)
NASDAQ
$1.36+$0.03 (+2.26%)
Price as of Sep 11, 2026 7:30 PM EDT- $205.5MMarket Cap
- 3.10%1-Year Change
- BiotechnologyIndustry
Coherus Onco (CHRS)
$1.36+$0.03 (+2.26%)
CHRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.33 | ||
Change | -$0.01 (-0.75%) | ||
Open | $1.38 | ||
High | $1.38 | ||
Low | $1.32 | ||
Previous Close | $1.34 | ||
Volume | 529,193 | ||
30-Day Average Volume | 1,077,520 | ||
1-Week Change | -6.34% | ||
1-Month Change | 9.92% | ||
1-Year Change | 3.10% | ||
3-Year Change | -73.66% | ||
5-Year Change | -91.36% | ||
Fundamentals | |||
Shares Outstanding | 154.5M | ||
Total Assets | $191.2M | ||
Market Cap | $205.5M | ||
Enterprise Value | $159.8M | ||
Period: QTR TTM FY | |||
Revenue | $14.3M | ||
Net Income | -$20.6M | ||
Free Cash Flow | -$62.1M | ||
EBIT | -$18.3M | ||
EBITDA | -$17.4M | ||
Net Working Capital | $58.3M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 3 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue